Skip to main content
. 2022 Nov 30;12:1035155. doi: 10.3389/fcimb.2022.1035155

Figure 1.

Figure 1

IgG anti-RBD levels on day 30 and 240 stratified by vaccine type, gender, age, and comorbidities. Violin plots of IgG anti-RBD levels in BAU/ml stratified according to vaccine type [(A) mRNA-1273 or BNT162b2]; gender [(B) male or female]; age ranges [(C) from 20 to 29 years old, 30-39 years, 40-49 years, 50-59 years, and 60-69 years]; and the presence of comorbidities [(D) no comorbidities, one comorbidity, or more than one comorbidity]. The median (black line) and quartiles (white lines) are represented in each violin plot. IgG anti-RBD levels were calculated in international units (BAU/ml). On day 30, the dotted line at 5,680 BAU/ml indicates the higher limit of quantification. A Kruskal Wallis test and a Dunn’s multiple comparisons test were performed for each variable. * p-value < 0.05, ** p-value < 0.01, **** p-value < 0.0001.